Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronabinol + acetazolamide crossover dose-finding study in obstructive sleep apnoea
ACTRN12620000916943Phase 2Completed
- Sponsor
- Incannex Healthcare
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dronabinol and acetazolamide in obstructive sleep apnea hypopnea syndrome (OSAHS) (6 arms), sponsored by Incannex Healthcare. Primary endpoint: Change in apnoea hypopnoea index compared with baseline. Started Nov 2020; status: completed.
02
Drugs
dronabinolacetazolamide
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ACTRN12620000916943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12620000916943.